Somnigroup International (SGI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
18 Mar, 2026Executive summary
Annual meeting scheduled for May 13, 2026, with virtual participation and voting options via internet, phone, or mail.
Four key proposals: election of eight directors, ratification of Ernst & Young LLP as auditors, advisory say-on-pay vote, and amendment to increase authorized common stock to 1 billion shares.
Board recommends voting FOR all proposals; only common stockholders as of March 16, 2026, may vote.
Company achieved $7.5 billion in net sales, $2.70 adjusted EPS, and $1.4 billion adjusted EBITDA in 2025, outperforming industry peers despite market headwinds.
Voting matters and shareholder proposals
Proposal 1: Elect eight directors for one-year terms; majority vote required.
Proposal 2: Ratify Ernst & Young LLP as independent auditors for 2026; majority vote required.
Proposal 3: Advisory vote to approve executive compensation; majority vote required.
Proposal 4: Amend Certificate of Incorporation to increase authorized common stock from 500 million to 1 billion; majority of outstanding shares required.
Board unanimously recommends FOR all proposals.
Shareholder proposals for 2027 proxy must be received by December 1, 2026.
Board of directors and corporate governance
Board consists of a majority of independent directors per NYSE rules; all committee members are independent.
Board held seven meetings in 2025; all directors attended at least 75% of meetings.
Lead Director role established for independent oversight; regular executive sessions held.
Board diversity emphasized, with directors bringing varied backgrounds in finance, operations, and international business.
Proxy access and related party transaction policies in place.
Latest events from Somnigroup International
- 24% EPS CAGR to 2028, $225M synergies, and global scale drive growth and margin expansion.SGI
Investor Day 202625 Mar 2026 - Q4 sales up 55%, adjusted EPS up 20%, 2026 guidance strong, dividend raised 13%.SGI
Q4 202517 Feb 2026 - FTC litigation delays merger, but management expects resolution and remains committed to the deal.SGI
Status Update3 Feb 2026 - EPS up 15% on higher margins despite sales decline; Mattress Firm deal faces FTC challenge.SGI
Q2 20242 Feb 2026 - Sales up 1.8%, EPS up 14.1%, and Mattress Firm acquisition faces FTC litigation.SGI
Q3 202416 Jan 2026 - Acquisition of Mattress Firm completed, creating Somnigroup and accelerating global bedding leadership.SGI
Investor Update9 Jan 2026 - Q1 sales up 35% to $1.6B; net loss on one-time costs; adjusted EPS $0.49; leverage 3.51x.SGI
Q1 20258 Jan 2026 - Q4 sales reached $1.21B, 2025 EPS guidance up 10%, $100M synergies targeted by 2028.SGI
Q4 20248 Jan 2026 - Proxy covers director elections, auditor ratification, pay, and strong ESG and governance focus.SGI
Proxy Filing1 Dec 2025